BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen D, Zhang X, Li Z, Zhu B. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages. Theranostics 2021;11:1016-30. [PMID: 33391518 DOI: 10.7150/thno.51777] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu J, Liu Z, Pu Y, Xu J, Zhang S, Bao Y. Green synthesized gold nanoparticles from Pseudobulbus Cremastrae seu Pleiones show efficacy against hepatic carcinoma potentially through immunoregulation. Drug Deliv 2022;29:1983-93. [PMID: 35762637 DOI: 10.1080/10717544.2022.2092238] [Reference Citation Analysis]
2 Li M, Xu H, Qi Y, Pan Z, Li B, Gao Z, Zhao R, Xue H, Li G. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression. Oncogene 2022. [PMID: 36085418 DOI: 10.1038/s41388-022-02457-w] [Reference Citation Analysis]
3 Zhuang Z, Gao C, Li Y. Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/6962056] [Reference Citation Analysis]
4 Pan QF, Ouyang WW, Zhang MQ, He S, Yang SY, Zhang J. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation. J Cell Commun Signal 2022. [PMID: 36042157 DOI: 10.1007/s12079-022-00684-0] [Reference Citation Analysis]
5 Pu Y, Zhu J, Xu J, Zhang S, Bao Y. Antitumor effect of a polysaccharide from Pseudostellaria heterophylla through reversing tumor-associated macrophages phenotype. Int J Biol Macromol 2022;220:816-26. [PMID: 35988728 DOI: 10.1016/j.ijbiomac.2022.08.111] [Reference Citation Analysis]
6 Guo W, Liu G, Guan J, Chen Y, Zhao Y, Wang K, Bai O. Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment. Front Oncol 2022;12:977266. [DOI: 10.3389/fonc.2022.977266] [Reference Citation Analysis]
7 Sutton TL, Patel RK, Anderson AN, Bowden SG, Whalen R, Giske NR, Wong MH. Circulating Cells with Macrophage-like Characteristics in Cancer: The Importance of Circulating Neoplastic-Immune Hybrid Cells in Cancer. Cancers 2022;14:3871. [DOI: 10.3390/cancers14163871] [Reference Citation Analysis]
8 Nwabo Kamdje AH, Seke Etet PF, Kipanyula MJ, Vecchio L, Tagne Simo R, Njamnshi AK, Lukong KE, Mimche PN. Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential. Front Endocrinol 2022;13:927390. [DOI: 10.3389/fendo.2022.927390] [Reference Citation Analysis]
9 Zhang C, Zeng Y, Guo X, Shen H, Zhang J, Wang K, Ji M, Huang S. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front Genet 2022;13:923737. [DOI: 10.3389/fgene.2022.923737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wang S, Liu G, Li Y, Pan Y. Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment. Front Immunol 2022;13:840029. [DOI: 10.3389/fimmu.2022.840029] [Reference Citation Analysis]
11 Zhang W, Shi Y, Li H, Yu M, Zhao J, Chen H, Kong M. In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation. Carbohydrate Polymers 2022;288:119418. [DOI: 10.1016/j.carbpol.2022.119418] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shen T, Zhang J, Wang Y, Liu B. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma. J Immunol Res 2022;2022:8443392. [PMID: 35733916 DOI: 10.1155/2022/8443392] [Reference Citation Analysis]
13 Dong K, Liu J, Zhou W, Zhang G. Exploring the Relationship Between Senescence and Colorectal Cancer in Prognosis, Immunity, and Treatment. Front Genet 2022;13:930248. [DOI: 10.3389/fgene.2022.930248] [Reference Citation Analysis]
14 Wang Q, Shen X, Chen G, Du J. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers (Basel) 2022;14:2928. [PMID: 35740594 DOI: 10.3390/cancers14122928] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tian LR, Lin MZ, Zhong HH, Cai YJ, Li B, Xiao ZC, Shuai XT. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. Biomater Sci 2022. [PMID: 35686599 DOI: 10.1039/d2bm00650b] [Reference Citation Analysis]
16 Li Y, Ren H, Cao J. Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.109005] [Reference Citation Analysis]
17 Zhang Y, Li J, Yang F, Zhang X, Ren X, Wei F. Relationship and prognostic significance of IL-33, PD-1/PD-L1, and tertiary lymphoid structures in cervical cancer. J Leukoc Biol 2022. [PMID: 35501298 DOI: 10.1002/JLB.5MA0322-746R] [Reference Citation Analysis]
18 Schweer D, Mcatee A, Neupane K, Richards C, Ueland F, Kolesar J. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. Cancers 2022;14:2220. [DOI: 10.3390/cancers14092220] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Malla R, Padmaraju V, Kundrapu DB. Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer. Life Sci 2022;301:120572. [PMID: 35489567 DOI: 10.1016/j.lfs.2022.120572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Li Q, Chen L, Jin H, Zhao Y, Hao Z, Ma X. Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis. Clin Med Insights Oncol 2022;16:11795549221084851. [PMID: 35355514 DOI: 10.1177/11795549221084851] [Reference Citation Analysis]
21 Park K, Veena MS, Shin DS. Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies. Front Cell Dev Biol 2022;10:830208. [PMID: 35345849 DOI: 10.3389/fcell.2022.830208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Shen R, Liu D, Wang X, Guo Z, Sun H, Song Y, Wang D. DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling. Front Cell Dev Biol 2021;9:828657. [PMID: 35265630 DOI: 10.3389/fcell.2021.828657] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Reference Citation Analysis]
24 Tong W, Wang G, Zhu L, Bai Y, Liu Z, Yang L, Wu H, Cui T, Zhang Y. Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response. Front Mol Biosci 2022;8:793445. [DOI: 10.3389/fmolb.2021.793445] [Reference Citation Analysis]
25 Mirzaei R, Sabokroo N, Ahmadyousefi Y, Motamedi H, Karampoor S. Immunometabolism in biofilm infection: lessons from cancer. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00435-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
26 Chen J, Liao Y, Li R, Luo M, Wu G, Tan R, Xiao Z. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer. Technol Cancer Res Treat 2022;21:15330338221090093. [PMID: 35509211 DOI: 10.1177/15330338221090093] [Reference Citation Analysis]
27 Duan S, Wang S, Huang T, Wang J, Yuan X. circRNAs: Insight Into Their Role in Tumor-Associated Macrophages. Front Oncol 2021;11:780744. [DOI: 10.3389/fonc.2021.780744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M, Moustaid-Moussa N, Hussain F, Rahman SM. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth. Int J Mol Sci 2021;22:6526. [PMID: 34207035 DOI: 10.3390/ijms22126526] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
29 Wang H, Yung MMH, Ngan HYS, Chan KKL, Chan DW. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression. Int J Mol Sci 2021;22:6560. [PMID: 34207286 DOI: 10.3390/ijms22126560] [Cited by in F6Publishing: 18] [Reference Citation Analysis]